Large Multi-functional Microwave Therapeutic Equipment with Computers

¨ Features :
With the principle that the microwave can make the biologic tissue generate the pyrogenic effect, the multi-functional microwave therapeutic equipment can stanch, clotting, the pathologic change tissues or amelioration blood circulation of local tissue. It is also an antiphlogistic, detumescent and analgesic therapeutic equipment.

Owing to the optimum design with the imported magnetron and the high frequency connector, the security and the qualifications satisfy national standards.

¨ Application:

n Department of gynaecology and obstetrics: episioitis, colpitis, annexitis, pelvic inflammation, babbit adenocele, cerical erosion, polyposis, condyloma, functional metrorrhagia.

n Department of dermatology: hemostasis of surgery, various acute inflammations, ulceration of skin, berpes zoster, pointed condyloma, haemangioma, hircismus, corn, and etc.

n Department of otorhinolaryngology: chronic rhinitis, inferior nasal clip hypertrophy, nasal polyp, epistaxis, nasosinusitis, nasopharyngeal darcinoma, tonsillitis, cyst of epiglottis, and etc.

n Anorectal department: internal and external hemorrhoids, anal fissure, polypus, eczema of anus, proctitis, papilloma, and etc.

n Digestion department: hemorrhage of digestive tract, polypus, ulcer, gastritis, esophagus stenosed, and etc.

¨ Computer control:

Computer and microwave are integrated, high-class and powerful.

Clicking the button of the mouse lightly, it can do anything for you.

¨ Manual control:
Through front-panel control to therapy, physiotherapy, ignition clotting, hemostasis, and etc.

¨ Optimal indication:

Various prostatitis and prostatitis hypertrophy of male, pelvic inflammation, various colpitis, hysteromyoma and venereal sequela of female.

¨ Technical parameter:

Current supply: 220V/50Hz/350W

Frequency of operation: 2450±50MHz

Output impedance: 50Ω

Power consumption: ≤260W

Temperature control extension: 35℃-50℃

Continuous running hours: >8hours

Therapeutic time: 1-90min/s (adjustable)

Work atmosphere: temperature 5℃-40℃ humidity <80%

Size: 450x550x1300mm

Weight: 50Kg

Computer control method: RS-232C serialization

Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and in vitro diagnostic reagents in the field of genetic testing and molecular diagnostics. With its own sustainable development and potential values, Tianlong has received investments from SK Group, the 57th largest company in the Fortune Global 500 list, and Kehua Bio-Engineering, a listed company in China, in 2012 and 2018.



As a high-tech enterprise in China, Tianlong Technology is responsible for many major scientific research and industrialization projects such as the National Key Research and Development Program, the National Special Project for the Development of Major Scientific Instruments and Equipment, and the National Science and Technology Support Program. ISO9001-certified and 13485-standard, Tianlong now has hundreds of products such as nucleic acid extractor, automated nucleic acid workstation, gene amplification instruments, real-time PCR instruments, ATP fluorescence detector and supporting test reagents. over 50 products have been approved by NMPA with medical device registration certificates, and more than 20 products have been approved by EU (CE) and KFDA (South Korea).



Tianlong products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc., and have contributed to the prevention and control of various major epidemics such as avian flu, Ebola, MERS, African swine fever and neonatal pneumonia. At present, Tianlong is serving more than 2,000 customers in more than 40 countries and regions including, Korea, the United States, France, Germany, Denmark, the United Arab Emirates, Pakistan, and so on.



At the end of 2019, after the outbreak of the COVID-19 epidemic, Tianlong quickly launched SARS-CoV-2 rapid nucleic acid detection solution, successively detected the first positive samples in many provinces in China, and made a great contribution to the epidemic prevention and control globally. Tianlong successively received letters of thanks from the State Council of China, the National Center for Disease Control of China, and the Slovakian government. Tianlong was then reported by CCTV News, Xinhua News Agency, People's Daily and other authoritative media.



In the face of future opportunities and challenges, we will continue to create first-class molecular diagnostic products and work hard for human health in a more open way of cooperation with all walks of life.